Jeffrey Osterman

Partner at Paul, Weiss

Speaker

Jeffrey Osterman is Global Co-Head of Intellectual Property & Technology Transactions and Chair of Life Sciences Licensing & Collaboration Transactions. He regularly advises major pharmaceutical companies in connection with licensing and collaboration agreements and manufacturing and supply arrangements. He has significant experience in numerous transactions involving novel therapeutic modalities, including genetic medicine and AI-assisted target and drug discovery. Jeffrey also regularly leads the technology and intellectual property aspects of major corporate transactions, including commercial arrangements associated with such transactions; and advises on the treatment of intellectual property matters in bankruptcy cases.

Ranked Band 1 by Chambers in the Technology category, Jeffrey is described by clients as “by far the premier licensing and collaboration attorney in the country” and “a fierce advocate for his clients, equipped with an arsenal of industry-specific knowledge.” Jeffrey is recognized by the Legal 500 as a “Leading Lawyer” in the Media, Technology and Telecoms: Technology Transactions category (2016-2025) and is recommended in the Patents: Licensing, Technology Transactions (2015-2025), Media and Entertainment: Transactional (2016-2025) and Healthcare: Life Sciences (2016-2025) categories.